MOSCOW: Russia on Saturday approved a third coronavirus vaccine for domestic use, Prime Minister Mikhail Mishustin said on state TV, though large-scale clinical trials of the shot, labelled CoviVac and produced by the Chumakov Centre, have yet to begin.
Russia has already approved two COVID-19 vaccines, including the Sputnik V shot, developed by Moscow's Gamaleya Institute, following a similar approach of granting approval before seeing any late-stage trial results.
The preemptive approvals had raised concerns among some scientists in the West, but inoculations with those first two shots began on a mass scale in Russia only after trials were concluded and showed success.
Sputnik V was approved in August and late-stage trials began in September. Mass vaccination was launched in December, after preliminary trial results showed the vaccine to be 91.4% effective.
Since then, more than two million Russians have been vaccinated with at least the first dose of Sputnik V, Health Minister Mikhail Murashko said on Feb. 10.
Rollout of a second vaccine, developed by the Vector Institute in Novosibirsk, is beginning.
"Today, Russia is the only country to have already three vaccines against COVID-19," Prime Minister Mishustin said.
The Chumakov Centre, founded in 1955 in St Petersburg by Mikhail Chumakov, is known for its work with U.S. scientist Albert Sabin at the height of the Cold War, which led to the production of the widely-used polio vaccine.
DIFFERENT TYPE OF VACCINE
Unlike the Sputnik V vaccine, which uses a modified harmless cold virus that tricks the body into producing antigens to help the immune system prepare for a coronavirus infection, the CoviVac vaccine is a "whole-virion" vaccine.
This means it is made of a coronavirus that has been inactivated, or stripped of its ability to replicate.
"The vaccine we have developed... reflects the whole history of Russian, as well as global, vaccine science," the Chumakov Centre's director, Aidar Ishmukhametov, said on Saturday.
The advantage, according to virologist Alexander Chepurnov, cited by outlet Lenta.Ru, is that CoviVac includes all elements of the virus, creating a broader immune response that is likely to protect against any variants.
However, testing Russia's COVID-19 shots against SARS-CoV-2 variants that have emerged in the UK, South Africa and elsewhere is in its early stages. President Vladimir Putin on Monday ordered a review of Russia's COVID-19 vaccines to be presented by March 15 assessing their ability to protect against the new variants.
RESULTS SO FAR
Globally, one other major vaccine candidate - India's COVAXIN by Bharat Biotech - uses the "whole-virion" approach.
India's drug regulator has touted the shot's ability to act against the whole body of a virus instead of just its "spike-protein" tip, potentially making it more effective in case of mutations.
The CoviVac shot is given in two doses, 14 days apart. It is transported and stored at normal fridge temperatures, of 2 to 8 degrees Celsius (35.6 to 46.4 Fahrenheit), Deputy Prime Minister Tatiana Golikova said in a government briefing in January.
The shot has already been tested for safety on 200 people aged between 18 and 60, Ishmukhametov told the state-run Vesti-24 news channel in late January.
This early-stage trial began on Sept. 21 last year, according to the state clinical trials register. It showed no side-effects, including no rise in temperature, Ishmukhametov said.
Mid-stage trials to test volunteers' immune responses were ongoing, he said at the time.
Only a placebo-controlled, large-scale trial could ascertain effectiveness, he added. This is due to begin now that the go-ahead has been granted.
The first 120,000 doses, however, will be produced and released to the national inoculation programme in March, Mishustin said.
Then, the Chumakov Centre will produce around half a million doses per month on its platforms, Ishmukhametov said on Saturday.
Deputy Prime Minister Golikova also announced on Saturday that Russia will produce 88 million vaccine doses in the first half of this year, including 83 million Sputnik V doses.
Reuters
Sat Feb 20 2021
Russian Prime Minister Mikhail Mishustin chairs a meeting with senior executives of the Central Office of Russian Government in Moscow, Russia, Jan 19, 2021. REUTERSpic
Lawsuit accuses major food companies of marketing 'addictive' food to kids
The lawsuit claims food companies knowingly made harmful, addictive products, engineered to keep consumers hooked.
Malaysia-Australia to continue enhancing defence cooperation
The decision was made at the 4th Malaysia-Australia Joint Defence Programme High-Level Committee Meeting, says Datuk Seri Mohamed Khaled.
Rise in East Coast flood victims; Perak, Johor unchanged
In Terengganu, the number of victims in the state swelled to 5,853 people.
South Korea police raid Yoon office over failed martial law as impeachment vote looms
Presidential security official says, the raid widens investigation into the embattled leader's failed attempt to impose martial law.
South Korea police chief arrested as Yoon impeachment looms over failed martial law
Cho Ji-ho is accused of deploying police to block lawmakers from entering parliament after Yoon Suk-Yeol declared martial law on Dec. 3.
Rebel-backed figure takes charge as Syria's interim prime minister
Mohammed al-Bashir says he would lead the interim authority until March 1.
Article 19 & CIJ call for revisions to protect rights in Online Safety Bill 2024
ARTICLE 19 and the Centre for Independent Journalism are concerned about specific provisions of the Online Safety Bill 2024.
South Korea ex-defence minister accused of role in martial law tries to commit suicide, official says
Former South Korean Defence Minister Kim Yong-hyun, has tried to commit suicide inside a detention centre, a justice ministry official told.
Stronger ringgit benefits cocoa farmers, reduces agricultural input import costs - MPIC
The reduced import costs would lower production costs for smallholders while boosting their profit margins, it said.
The strength of TV and BVOD ensures brand longevity for advertisers
The combination of mainstream television (TV) and broadcaster video-on-demand (BVOD) is emerging as a key strategy.
Issue of mat rempit stunts on highway among focus in Dewan Rakyat today
Also among today's highlights are questions about plans to enact Religious Harmony Act to address issues of religious polemics in Malaysia.
South Korea's Yoon gave orders to 'drag out' MPs during martial law, officer says
Yoon Suk-Yeol is now the subject of criminal investigations on insurrection charges.
Israel 'more optimistic' on prospects of Gaza hostage deal
Israel's Foreign Minister says indirect negotiations were under way about the return of about 100 hostages.
Davos 2025: What to expect and who's coming?
The 2025 Annual Meeting of the World Economic Forum takes place from 20-24 January in Davos, Switzerland.
Undiagnosed disease in Congo puts children, malnourished at risk, WHO says
The WHO says all severe cases reported to be severely malnourished, and majority of cases were children, particularly those aged under five.
Europe's new migrant hotspot races to cope with surging deaths
The number of migrants arriving from the West African coast in the Spanish archipelago is running at all-time highs.
'Squid Game' stars confident South Korea will overcome martial law turmoil
Stars of mega-hit series "Squid Game" are confident South Korea will overcome the crisis.
Bahrain celebrates National Day and 50 years of friendship with Malaysia
The event highlighted Bahrains rich cultural legacy, visionary leadership, and its commitment to fostering global partnerships.
Israel says it will destroy Syria's heavy strategic weaponry
Israel hopes to head off any threat that could emerge in the fallout of president Bashar al-Assad's overthrow.
Pahang Palace will not issue any statement on royal addendum
Pahang State Legal Advisor says the decision was made on the advice of Pahang MB to respect the court proceedings.